Ginkgo Bioworks Holdings, Inc. (DNA)
After hours:
| Previous close | 8.65 |
| Open | 8.75 |
| Bid | 0.00 x 3000 |
| Ask | 0.00 x 1000 |
| Day's range | 8.25 - 9.75 |
| 52-week range | 7.91 - 15.86 |
| Volume | |
| Avg. volume | 8,006,070 |
| Market cap | 14.481B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.69 |
| Earnings date | 15 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.83 |
- GlobeNewswire
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. (DNA) Investors and Encourages Investors to Contact the Firm Before January 18, 2022
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. (“Ginkgo” or the “Company”) (NYSE: DNA) (NASDAQ: SRNG) securities from May 11, 2021 through October 5, 2021, inclusive (the “Class Period”). Investors have until January 18, 2022 to apply to
- GlobeNewswire
GINKGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 04, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings, Inc. (“Ginkgo” or the “Company”) (NYSE: DNA) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Ginkgo securities between May 11, 2021 and October 5, 2021, both dates inclusive (th
- GlobeNewswire
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE: DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc.
NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion no later than January 18, 2022 in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. (“Ginko”) (NYSE: DNA, SRNG) between May 11, 2021 and October 5, 2021, inclusive (the “Class Perio
